Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.

@article{Hermansen2007BodyweightCA,
  title={Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.},
  author={Kjeld Hermansen and Lene Sundahl Mortensen},
  journal={Drug safety},
  year={2007},
  volume={30 12},
  pages={
          1127-42
        }
}
The majority of patients with type 2 diabetes mellitus are overweight or obese at the time of diagnosis, and obesity is a recognised risk factor for type 2 diabetes and coronary heart disease (CHD). Conversely, weight loss has been shown to improve glycaemic control in patients with type 2 diabetes, as well as to lower the risk of CHD. The traditional pharmacotherapies for type 2 diabetes can further increase weight and this may undermine the benefits of improved glycaemic control. Furthermore… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 71 extracted citations

Similar Papers

Loading similar papers…